THE BJP SAYS IT is a conspiracy to destabilise India's financial markets. The Congress wants a joint parliament committee probe. Irrespective of which side you are on, the latest report by Hindenburg Research has put the market regulator Securities and Exchange Board of India and its chairperson Madhabi Puri Buch in a spot over conflict of interest. It also raises broader compliance issues the very regulator has looked to address over the years.
Founded by Nathan Anderson, the New-York-based Hindenburg specialises in forensic financial research. In particular, it looks for situations where companies might have accounting irregularities, bad actors in management, undisclosed transactions, unethical business practices, undisclosed regulatory issues and the like. And it also aims to profit from its research through short-selling, a trading strategy where stock traders take a position that a particular stock price will fall. Often its report itself drives the stock price lower, like it did in January 2023, when its report on Adani Group alleging accounting fraud, stock price manipulation and money laundering wiped off around $150 billion in the group's market cap. Hindenburg made $4.1 million revenue by shorting Adani securities on behalf of its client.
In its latest report, Hindenburg alleged that despite enough evidence, SEBI did not act against Adani. It alleges that Buch and her husband, Dhaval, had investments in the same obscure offshore funds used by Adani Group chairman Gautam Adani's brother Vinod. It also alleged that while Dhaval was a senior adviser at American investment management company Blackstone and Buch was a SEBI official, two Blackstone-sponsored real estate investment trusts (REITs) received the approval to go public in India, and after she became chair, SEBI implemented several REITs regulations that benefited Blackstone.
هذه القصة مأخوذة من طبعة August 25, 2024 من THE WEEK India.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 25, 2024 من THE WEEK India.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Hat-Trick Or Has-Beens?
India look to win their third straight Test series in Australia, but ageing superstars and recent humiliation at home have cast a shadow on their hopes
Constipation Can Put Your Heart At Risk
PEOPLE WITH CONSTIPATION have an increased risk of major cardiac events, including heart attack, stroke and heart failure, especially if they also have high blood pressure, finds an international study published in the American Journal of Physiology-Heart and Circulatory Physiology.
Too Much Sitting Can Accelerate Ageing
SITTING FOR EXTENDED PERIODS can harm the heart and accelerate ageing, even if you are young and get the minimum recommended amount of daily exercise, according to a US study published in the journal PLOS One.
Efficiency and innovation
As health care evolves, professionals must employ innovative methods to refine their skills
Level up
Only 30 per cent of needy patients are able to undergo transplant in India; we need more dedicated transplant centres
HOPE STEMS FROM A CELL
While stem cell therapies have shown success in treating blood disorders, orthopaedic ailments, autoimmune diseases and eye issues, there is hope that they can one day treat patients with heart disease, blindness, Parkinson's, HIV, diabetes and spinal cord injuries
Mind matters
Your mindset can limit or expand your physical ability
Cutting edge
Would you go under the knife if a robot was the one holding it? Or would you say, \"No way, I need a human touch\"? You might have to decide soon because a robot that can imitate skilled human surgeons is already here.
The smallest cut
Minimally invasive surgeries have a bright future, with virtual reality and 3D procedures offering greater precision and AI on the horizon
Signalling a revolution
Canadian scientist and entrepreneur Sachdev Sidhu is focused on bringing cutting-edge antibody engineering to his country of origin
